Year None2022202120202019201820172016201520142012 May 10, 2022 Graybug Vision Reports First Quarter 2022 Financial Results and Recent Corporate Developments Apr 27, 2022 Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting Apr 18, 2022 Graybug to Present at the 2022 ASCRS Annual Meeting Apr 13, 2022 Graybug Vision Appoints Dirk Sauer to Board of Directors Mar 30, 2022 Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023 Mar 21, 2022 Graybug Vision to Host Virtual R&D Day on March 30, 2022 Mar 10, 2022 Graybug Vision Reports Full Year 2021 Financial Results and Recent Corporate Developments Feb 03, 2022 Graybug to Participate in Three Upcoming Medical and Investor Conferences Jan 20, 2022 Graybug Vision Makes Key Hires to Further Build Momentum Behind its Pipeline
May 10, 2022 Graybug Vision Reports First Quarter 2022 Financial Results and Recent Corporate Developments
Apr 27, 2022 Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting
Mar 30, 2022 Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023
Mar 10, 2022 Graybug Vision Reports Full Year 2021 Financial Results and Recent Corporate Developments
